Latest Headlines
-
Novotech Honored With Frost & Sullivan's 2024 Best Practices Company Of The Year Award For Leadership In Biotech CRO Services
9/10/2024
Novotech, the global full-service clinical Contract Research Organization (CRO), is proud to announce that it has been awarded the prestigious 2024 Global Company of the Year Award by Frost & Sullivan. This recognition underscores Novotech’s commitment to accelerating clinical development for biotech companies through innovative solutions, advanced analytics, and a comprehensive global reach.
-
Somite Therapeutics and OmniaBio Inc. Announce Collaboration To Advance Somite's Cell Therapy Flagship Program
9/9/2024
Somite Therapeutics, a tech-bio company harnessing big data and AI to pioneer novel cell replacement therapies, and OmniaBio Inc., a technology-driven cell and gene therapy CDMO founded by CCRM, today announced a cell therapy development and manufacturing collaboration for producing SMT-M01, Somite’s flagship program for Duchenne muscular dystrophy (DMD).
-
Novotech Unveils 2024 Report On Global Gastric Cancer Clinical Trials And Cutting-Edge Therapeutics
9/6/2024
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released its latest industry report, Gastric Cancer- Global Clinical Trial Landscape (2024).
-
Novotech Releases 2024 Report On Pancreatic Cancer Clinical Trials And Drug Development
9/5/2024
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released its latest industry report, Pancreatic Cancer- Global Clinical Trial Landscape (2024).
- Avance Clinical GlobalReady Site Partnership Network Expands Rapidly To 2,000 Site Members 9/4/2024
-
NEW: CGT Industry's First Aseptic Micro-Connector For Cryogenic Applications
9/4/2024
The MicroCNX® ULT Series can be frozen to -190°C and are compatible with the tubing types most commonly used in developing advanced therapies including polyvinyl chloride (PVC).
-
Avance Clinical Wins 2024 Frost & Sullivan Award For Global Biotech CRO Excellence
8/28/2024
Avance Clinical, a leading global CRO specializing in clinical trials for the biotech sector, has won the prestigious 2024 Frost & Sullivan Best Practices Customer Value Leadership Award for Global Biotech CRO Excellence.
-
Transforming The Future Of Medicine With RNA-Based Therapies
8/28/2024
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released its latest industry report, RNA Therapies — Global Clinical Trial Landscape (2024)
-
Small-Scale Aseptic Filling OEM AST Announces Sean Silvey As New Product Manager
8/23/2024
AST is excited to introduce Sean Silvey, who is joining us as Product Manager. Sean has been leading critical product development and technical communication initiatives for over a decade and has an extensive background in mechanical engineering. Sean has a passion for connecting creative problem-solving and strategic thinking with customer-centered solutions. As part of AST’s product development team, Sean will play an integral part in product implementation, forecasting, market intelligence, and identifying opportunities for innovation within the life science industry.
-
"How Can Drug Manufacturing Utilize Technology To Improve Efficiency And Reduce Waste?" Event Planned In South San Francisco For Sept 19
8/22/2024
How can manufacturing utilize technology to improve efficiency and reduce waste? Find out, and learn more at Foundry & Lux.